Global Bifidobacterium Market Size By Type (Y Shape, Rod Shape), By Application (Microecological Preparation, Bifidobacterium Yogurt), By Region, And Segment Forecasts, 2023 to 2032

The Global Bifidobacterium Market was valued at USD 1.24 billion in 2023 and is projected to reach USD 2.58 billion by 2031, expanding at a CAGR of 9.5% during the forecast period from 2023 to 2031. The market is witnessing robust growth due to the increasing consumer awareness regarding gut health, the expanding application of probiotics in functional foods and beverages, and a growing emphasis on preventive healthcare. Bifidobacterium, a beneficial genus of bacteria, is extensively used in dietary supplements, infant nutrition, and fortified food products for its immunity-boosting and digestive health benefits.

Drivers:

1. Rising Awareness of Gut Health and Probiotics:

Consumers are becoming increasingly conscious of the link between gut microbiota and overall well-being. Bifidobacterium supplements are gaining popularity as they support digestion, improve immune responses, and enhance nutrient absorption.

2. Expansion of Functional Food and Beverage Industry:

The integration of probiotics into yogurts, health drinks, and snack bars has surged, with Bifidobacterium being a preferred strain due to its proven efficacy in enhancing digestive balance.

3. Increasing Infant Formula Demand:

The rise in working mothers and increasing awareness of infant health have fueled the demand for bifidobacterium-enriched infant formula, known for mimicking the gut flora of breastfed infants.

Restraints:

1. Stringent Regulatory Standards:

The probiotic industry faces rigorous approval processes, particularly in regions like Europe and North America, where substantiation of health claims is required, potentially slowing product launches.

2. Stability Challenges in Formulations:

Ensuring the survival of live Bifidobacterium strains through processing, packaging, and shelf life remains a significant formulation challenge, limiting its application in certain food and beverage formats.

Opportunity:

1. Growth in Personalized Nutrition:

The rise in personalized wellness solutions is creating new avenues for Bifidobacterium-based products tailored to individual microbiome profiles, especially via DTC (direct-to-consumer) platforms.

2. Expansion into Emerging Economies:

Countries like India, China, and Brazil are witnessing growing demand for probiotic supplements due to increasing disposable income, rising health awareness, and expanding retail channels.

Market by System Type Insights:

By strain type, Bifidobacterium bifidum dominated the market in 2023, driven by its wide application in dietary supplements and infant formula. However, Bifidobacterium longum is projected to be the fastest-growing segment due to its association with cognitive health and potential use in mental wellness formulations.

Market by End-use Insights:

In terms of end-use, the Dietary Supplements segment held the largest market share in 2023, accounting for more than 40% of global revenue. This is attributed to the increasing adoption of daily probiotic capsules and gummies. The Food & Beverage segment is expected to grow at a notable pace due to increasing fortification of beverages and dairy products with Bifidobacterium strains.

Market by Regional Insights:

North America led the global Bifidobacterium market in 2023, supported by high consumer awareness, favorable regulatory frameworks for probiotics, and the strong presence of nutraceutical companies. Asia-Pacific is anticipated to experience the highest CAGR over the forecast period, driven by rising health consciousness, growing middle-class population, and increasing product availability in countries like China, India, and Japan.

Competitive Scenario:

Prominent players in the global Bifidobacterium market include Chr. Hansen Holding A/S, DuPont Nutrition & Biosciences, Probi AB, Yakult Honsha Co., Ltd., Danone, Nestlé Health Science, Morinaga Milk Industry Co., Ltd., and Meiji Holdings Co., Ltd. These companies are actively engaged in strategic partnerships, clinical research, and product development to gain a competitive edge.

Scope of Work – Global Bifidobacterium Market

Key Market Developments:

In March 2023, Chr. Hansen launched a new Bifidobacterium strain targeting infant colic and digestive issues, enhancing its pediatric probiotic portfolio.

In September 2024, DuPont Nutrition & Biosciences partnered with a leading functional beverage brand in Japan to develop Bifidobacterium-infused ready-to-drink health products.

In January 2025, Probi AB received GRAS approval for a novel Bifidobacterium blend aimed at improving immune health in elderly populations.

FAQs:

1. What is the current market size of the Global Bifidobacterium Market?

The Global Bifidobacterium Market was valued at USD 1.24 billion in 2023.

2. What is the major growth driver of the Global Bifidobacterium Market?

The primary growth driver is the rising awareness of digestive health and the expanding use of probiotics in functional foods and supplements.

3. Which is the largest region during the forecast period in the Global Bifidobacterium Market?

North America held the largest share in 2023, but Asia-Pacific is expected to grow at the fastest rate.

4. Which segment accounted for the largest market share in Global Bifidobacterium Market?

The Dietary Supplements segment held the largest market share in 2023.

5. Who are the key market players in the Global Bifidobacterium Market?

Key players include Chr. Hansen Holding A/S, DuPont Nutrition & Biosciences, Probi AB, Danone, Nestlé Health Science, and Morinaga Milk Industry Co., Ltd.